Sun-Glizide MR Dosage & Drug Information

Concise Prescribing Info

Contents

Gliclazide

Indications/Uses

NIDDM (type 2).

Dosage/Direction for Use

1-4 tab as single daily dose.

Administration

Should be taken with food: Taken preferably before breakfast. Swallow whole w/ ½ glass of water.

Contraindications

Hypersensitivity to gliclazide, other sulfonylureas, sulfonamides. Unstable &/or IDDM particularly juvenile diabetes, diabetic ketoacidosis, diabetic coma; stress conditions eg, serious infection, trauma or surgery in the presence of hepatic disease or renal impairment. Pregnancy & lactation.

Special Precautions

Periodic assessment of CV, ophth, renal & hepatic status. Loss of blood sugar control may occur in cases of intercurrent disease or in stressful situations. Hypoglycaemic reactions. Low-calorie diet, prolonged strenuous exercise, alcohol intake or administration of combination of hypoglycaemic agents. Childn.

Adverse Reactions

Hypoglycaemia w/ signs of adrenergic counter-regulation. GI disturbances including abdominal pain, nausea, vomiting, dyspepsia, diarrhoea & constipation; transient visual disturbances.

View ADR Monitoring Form

Drug Interactions

Increased hypoglycaemic effect leading to possible onset of coma w/ miconazole, phenylbutazone (systemic route), alcohol, other antidiabetic agents, β-blockers, fluconazole, ACE inhibitors, H₂-antagonists, MAOIs, sulfonamides & NSAIDs. Diabetogenic effect of danazol. Increased blood glucose levels w/ chlorpromazine, ritodrine, salbutamol, terbutaline; possible ketosis w/ glucocorticoids & tetracosactrin. Potentiated effects of anticoagulants eg, warfarin.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.

Regulatory Classification

Presentation/Packing

Form

Sun-Glizide MR tab 30 mg

Packing/Price

30's

Sun-Glizide MR

gliclazide

Manufacturer:

Taiwan Biotech

Distributor:

SS Health